Zebra Technologies Strategic Investment in Apera AI Aims to Accelerate Industrial Automation Workflows Dow Futures Rise as Oil Prices Tumble on Potential Iran Deal Trump Notes No Rush Spain Blocks Access to Prediction Markets Kalshi and Polymarket Over Gambling Law Concerns US Consumer Prices Rise 38 in April Exceeding Expectations Allianz Travel Insurance Review Coverage Options and Market Considerations Oil Markets Approach Tipping Point as USIran Deal Prospects Emerge PSQ Holdings Inc PSQH Q1 2026 Earnings EPS Surprises to the Upside as Stock Declines VEL Q1 2026 Earnings EPS Beats Estimates by 52 Stock Rises MSAI Q1 2026 Earnings EPS Surprise Beats Estimates Stock Rises Amid Revenue Uncertainty VUZI Q1 2026 Earnings EPS Beat but Revenue Uncertainty Lingers GLPI Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Move ATHR Q1 2026 Earnings NarrowerThanExpected Loss Signals Improved Cost Management Faraday Future Intelligent Electric Inc Warrants FFAIW Hover at 001 Amid Flat Trading XFLT Shares Dip 138 as Floating Rate Income Trust Consolidates Below Resistance XTI Aerospace Inc XTIA Surges 7 as Shares Test Key Resistance Level MFAO Holds Steady Near 2520 as Senior Notes Trade in Tight Range Dingdong DDL Slips 091 as Stock Hovers Near Key Support Level Top Economist Tyler Cowen Says AIs Biggest Challenge Is Adjustment Not Unemployment UPS Q1 2026 Earnings EPS Beat Lifts Stock Amid Mixed Operating Environment Oyster Enterprises II Acquisition Corp Units OYSEU Holds Steady Near Trust Value as Market Watches for Merger Catalyst Invesco Ltd IVZ Q1 2026 Earnings EPS Misses Estimates Amid Market Headwinds KEP Q4 2025 Earnings EPS Misses Estimates as Utility Faces Headwinds NOAH Q3 2025 Earnings Strong EPS Despite Market Headwinds CBZ Q1 2026 Earnings EPS Surges 124 Above Estimates Driving Strong Profitability LMAT Q1 2026 Earnings Modest EPS Beat Amid Revenue Data Gap NMFC Q1 2026 Earnings EPS Misses Estimates as Net Investment Income Slightly Below Expectations CRVO Q1 2026 Earnings WiderthanExpected Loss as PreClinical Stage Company Reports No Revenue